Filament Health Corp.
FLHLF
$0.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -79.39% | -81.69% | -83.15% | -71.29% | 275.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -79.39% | -81.69% | -83.15% | -71.29% | 275.01% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -79.39% | -81.69% | -83.15% | -71.29% | 275.01% |
| SG&A Expenses | -39.85% | -39.01% | -37.39% | -36.39% | 2.93% |
| Depreciation & Amortization | -2.48% | -2.03% | -1.08% | 1.55% | 3.01% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -40.78% | -39.76% | -37.01% | -35.05% | 2.73% |
| Operating Income | 16.42% | 11.41% | 9.76% | 18.04% | 29.54% |
| Income Before Tax | 3.65% | 3.68% | 4.41% | 8.48% | 74.57% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.93% | 3.95% | 4.41% | 8.48% | 74.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.93% | 3.95% | 4.41% | 8.48% | 74.55% |
| EBIT | 16.42% | 11.41% | 9.76% | 18.04% | 29.54% |
| EBITDA | 14.14% | 10.02% | 9.34% | 18.86% | 30.76% |
| EPS Basic | 15.67% | 24.07% | 26.94% | 29.91% | 80.44% |
| Normalized Basic EPS | 30.12% | 36.63% | 38.02% | 39.55% | 43.92% |
| EPS Diluted | 15.67% | 24.07% | 26.94% | 29.91% | 80.44% |
| Normalized Diluted EPS | 30.12% | 36.63% | 38.02% | 39.55% | 43.92% |
| Average Basic Shares Outstanding | 14.64% | 25.16% | 27.04% | 26.44% | 30.51% |
| Average Diluted Shares Outstanding | 14.64% | 25.16% | 27.04% | 26.44% | 30.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |